2020 Benefit Year Closeout for the Coverage Gap Discount Program Invoicing Cycle

Relevant to: Part D Sponsors and Pharmaceutical Manufacturers

This memorandum is a reminder of the upcoming closeout of the benefit year 2020 (BY 2020) Coverage Gap Discount Program (CGDP) invoicing cycle. As with previous years, the BY 2020 invoicing cycle will conclude 37 months after the end of the benefit year and ends on January 31, 2024 with the Quarter 17 (Q17) invoice. Prescription Drug Event (PDE) records reporting gap discount amounts for benefit year 2020 that require submission, adjustment, or deletion for any reason must be submitted by this date to be included in the 2020 benefit year’s final CGDP invoice.

See the full guidance for more information.